Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD22 | P20273 | 5/20 | 0.58 |
| ▸ | MAG | P20916 | 3/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16373105 | 0.89 | CD22 (0.62) | CD22 | |
| SCHEMBL13679158 | 0.86 | CD22 (0.65) | CD22MAG | |
| SCHEMBL24630013 | 0.86 | CD22 (0.52) | CD22MAG | |
| SCHEMBL24629737 | 0.86 | CD22 (0.52) | CD22MAG | |
| SCHEMBL16841310 | 0.85 | CD22 (0.67) | CD22 | |
| SCHEMBL31225204 | 0.84 | CD22 (0.56) | CD22MAG | |
| SCHEMBL16841340 | 0.84 | CD22 (0.69) | CD22 | |
| SCHEMBL13907392 | 0.84 | CD22 (0.59) | CD22MAG | |
| SCHEMBL18083838 | 0.83 | CD22 (0.66) | CD22 | |
| SCHEMBL17029896 | 0.83 | CD22 (0.66) | CD22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090239760-A1 | Method for the Identification of New Leads for Drug Candidates | UNIVERSITY OF BASEL (CH) | 2009-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090239760-A1 | Method for the Identification of New Leads for Drug Candidates | MAG, PMP22, MAGI3 | CD22 677/4885MAG 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.